AZ, Pfizer/BioNTech vaccines ‘highly effective’ against Delta variant
AstraZeneca and Pfizer/BioNTech’s COVID-19 vaccines are ‘highly effective’ at protecting against the Delta (previously known as the Indian) variant, according to new real-world data from Public Health England (PHE). The analysis included 14,019 cases of the Delta variant, of which 166 were hospitalised, between 12 April and 4 June, looking at emergency hospital admissions in […]
CUREVAC VACCINE DISAPPOINTS IN KEY STUDY AMID ‘UNPRECEDENTED’ SPREAD OF VARIANTS
Dive Brief: An experimental coronavirus vaccine from drugmaker CureVac was only 47% effective at preventing COVID-19 in a preliminary analysis of results from a large clinical trial, a disappointing result that the German biotech company attributed to the widespread prevalence of virus variants. According to CureVac, the efficacy estimate could change as more of […]
Regeneron antibody cuts risk of COVID-19 death in UK study
Dive Brief: A major study found that Regeneron’s antibody treatment can reduce the risk of death for certain people hospitalized with COVID-19, the first definitive evidence a drug aimed at the coronavirus can lower mortality among the sickest patients. Regeneron’s combination antibody regimen cut the risk of death by 20% in patients who had […]